BMAL1 and metastatic melanoma: In fact, in metastatic melanomas, BMAL1 expression exhibited a strong positive correlation with the expression of dendritic cell markers, T-cell markers CD4 and CD8A, and T-cell activation/differentiation markers (Figure 2B).